The mRNA levels of MSTN and its receptor ActRIIb were increased by more than 50-to 100-fold in subcutaneous and visceral fat of ob/ob mice (a mouse model of obesity) compared with wild-type mice (52). Here, MSTN is linked to obesity disorder.